| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |